Matt Baer

Matt Baer is a Sr. Scientist specializing in Biophysics and Early Molecule Discovery at Lilly Oncology. Previously, they served as a Research Associate at Vivaldi Biosciences, developing vaccines for Influenza and SARS-CoV-2. Prior to that, they were a Student Researcher at the Eric D. Ross lab, where they cloned and characterized synthetic Prion-like Domains in yeast and contributed to an automated imaging analysis system. Matt holds a Master's degree in Biochemistry from Colorado State University, where they also completed their Bachelor's degree in the same field.